Skip to Content

Rule

Bar Code Label Requirement for Human Drug Products and Biological Products; Correction

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule; correction.

SUMMARY:

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 26, 2004 (69 FR 9120). The document included typographical and inadvertent errors. This document corrects those errors.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Philip L. Chao, Office of Policy and Planning (HF-23), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-0587.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In FR Doc. 04-4249, appearing on page 9120 in the Federal Register of Thursday, February 26, 2004, the following corrections are made:

Start Amendment Part

1. On page 9151, in the third column, the first sentence of the first full paragraph, is corrected to read “We estimate that the rule provides net benefits to society of $4.3 billion to $4.5 billion annually, depending on whether a discount rate of 3 percent or 7 percent is used.”

End Amendment Part Start Amendment Part

2. On page 9167, in the first column, the first sentence under the heading “

End Amendment Part Start Signature

Dated: March 31, 2004.

Jeffrey Shuren,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 04-7815 Filed 4-6-04; 8:45 am]

BILLING CODE 4160-01-S